News & Updates

Show Multimedia Only
Lifestyle changes improve cognition among people with resistant hypertension

Lifestyle changes improve cognition among people with resistant hypertension

21 Jul 2022

Individuals with resistant hypertension who undergo lifestyle modification have better cognitive function, and this benefit may be attributed to the reduced ambulatory systolic blood pressure (SBP) changes through weight loss, suggests a study.

21 Jul 2022
6-month secukinumab use improves outcomes in psoriatic arthritis

6-month secukinumab use improves outcomes in psoriatic arthritis

21 Jul 2022 byStephen Padilla

Real-world patients with psoriatic arthritis (PsA) who received and remained on secukinumab treatment for 6 months has attained minimal disease activity (MDA) and shown improvements in clinical manifestations, patient-reported outcomes, and work productivity at follow-up, reveals a study. The results are consistent with findings from clinical trials.

21 Jul 2022
Pre-eclampsia ups risk of nonsyndromic orofacial clefts

Pre-eclampsia ups risk of nonsyndromic orofacial clefts

21 Jul 2022

Only pre-eclampsia, among other hypertensive disorders of pregnancy, contributes to a higher risk of nonsyndromic orofacial clefts (NSOFCs) and its subtypes, a study has found.

21 Jul 2022
Women hospitalized with COVID-19 suffer from menstrual changes, worse mental health

Women hospitalized with COVID-19 suffer from menstrual changes, worse mental health

21 Jul 2022

COVID-19 appears to alter the menstrual cycle and impair mental health in women hospitalized for the disease, a recent study has found.

21 Jul 2022
Tirzepatide beneficial for shedding pounds in obese adults

Tirzepatide beneficial for shedding pounds in obese adults

21 Jul 2022

Once-weekly treatment with tirzepatide in adults with obesity appears to yield substantial and sustained reductions in body weight, according to the phase III SURMOUNT-1 trial.

21 Jul 2022